Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Kluba

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Cytotherapy|February 5, 2009
Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation abilityRichard Schäfer, Rainer Kehlbach, Michaela Müller, et al.
Stem Cell Research|October 30, 2016
Generation of induced pluripotent stem cells derived from a 77-year-old healthy woman as control for age related diseasesNatakarn Nimsanor, Ida Jørring, Mikkel A Rasmussen, et al.
Frontiers in Neurology|April 6, 2016
High-Resolution Microfluidic Single-Cell Transcriptional Profiling Reveals Clinically Relevant Subtypes among Human Stem Cell Populations Commonly Utilized in Cell-Based TherapiesRobert C Rennert, Richard Schäfer, Tonya Bliss, et al.
Stem Cells and Development|February 8, 2012
Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potentialGeorg Siegel, Petra Krause, Stefanie Wöhrle, et al.
Stem Cells and Development|April 17, 2020
Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or ChemotherapyMichaela Döring, Torsten Kluba, Karin Melanie Cabanillas Stanchi, et al.
British Journal of Haematology|March 23, 2011
Expression of blood group genes by mesenchymal stem cellsRichard Schäfer, Martina Schnaidt, Roland A Klaffschenkel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2023
The health-related quality of life of sarcoma patients treated with neoadjuvant versus adjuvant radiotherapy - Results of a multi-center observational studySusanne Singer, Sabine Semrau, Henriette Golcher, et al.
Stem Cells Translational Medicine|January 4, 2013
Shared cell surface marker expression in mesenchymal stem cells and adult sarcomasStefan Wirths, Elke Malenke, Torsten Kluba, et al.
Cells|December 16, 2020
Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic ProfileSabine Schleicher, Stefan Grote, Elke Malenke, et al.
Brain : a Journal of Neurology|June 28, 2014
Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifierTobias Bonifert, Kathrin N Karle, Felix Tonagel, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cytotherapy|February 5, 2009
Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation abilityRichard Schäfer, Rainer Kehlbach, Michaela Müller, et al.
Stem Cell Research|October 30, 2016
Generation of induced pluripotent stem cells derived from a 77-year-old healthy woman as control for age related diseasesNatakarn Nimsanor, Ida Jørring, Mikkel A Rasmussen, et al.
Frontiers in Neurology|April 6, 2016
High-Resolution Microfluidic Single-Cell Transcriptional Profiling Reveals Clinically Relevant Subtypes among Human Stem Cell Populations Commonly Utilized in Cell-Based TherapiesRobert C Rennert, Richard Schäfer, Tonya Bliss, et al.
Stem Cells and Development|February 8, 2012
Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potentialGeorg Siegel, Petra Krause, Stefanie Wöhrle, et al.
Stem Cells and Development|April 17, 2020
Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or ChemotherapyMichaela Döring, Torsten Kluba, Karin Melanie Cabanillas Stanchi, et al.
British Journal of Haematology|March 23, 2011
Expression of blood group genes by mesenchymal stem cellsRichard Schäfer, Martina Schnaidt, Roland A Klaffschenkel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2023
The health-related quality of life of sarcoma patients treated with neoadjuvant versus adjuvant radiotherapy - Results of a multi-center observational studySusanne Singer, Sabine Semrau, Henriette Golcher, et al.
Stem Cells Translational Medicine|January 4, 2013
Shared cell surface marker expression in mesenchymal stem cells and adult sarcomasStefan Wirths, Elke Malenke, Torsten Kluba, et al.
Cells|December 16, 2020
Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic ProfileSabine Schleicher, Stefan Grote, Elke Malenke, et al.
Brain : a Journal of Neurology|June 28, 2014
Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifierTobias Bonifert, Kathrin N Karle, Felix Tonagel, et al.
Pageof 6